Friday, January 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Army to Award Chemical Warfare Agent Research Contract to BBRI

by Global Biodefense Staff
July 2, 2012

US Army Medical Research Institute of Chemical Defense (USAMRICD) has issued an intent to award a sole source contract to Brentwood Biomedical Research Institute (BBRI) of Los Angeles, CA.

The services are in support of an on-going research protocol investigating the time course and mechanism of neuronal damage associated with chemical agent-induced seizures. The project is being executed under an interagency agreement between USAMRICD and the Biomedical Advanced Research and Development Authority (BARDA).

BBRI is currently collaborating with the USAMRICD to evaluate the effects of organophosphates and chemical warfare agents in the adult animal brain. The contract will allow for comparisons between juvenile and older animals, using the same techniques and quantification methods already in place.

BBRI scientists have extensive experience in neuronal injury, mechanisms of seizure-induced neuronal death in the immature brain, and in differentiating neuronal necrosis from neuronal apoptosis. The company is also recognized as leading researchers on seizure-based animal models.

  • View Profile: US Army Medical Research Institute of Chemical Defense
  • View Profile: Biomedical Advanced Research and Development Authority
Tags: Animal ModelsASPRAwardsBARDAHHSUSAMRICD

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC